Salvinorin A: Difference between revisions

>Dexhead42
m Removed extra apostrophe that preceded Sedation.
>David Hedlund
===Near-death experience===: pmid=30711788
Line 143: Line 143:


==Research==
==Research==
Salvinorin A is currently being researched in relation to its properties as an anti-addiction drug, and several analogs with improved pharmacokinetic profiles have been shown to have anti-addictive effects as well.<ref>http://www.ncbi.nlm.nih.gov/pubmed/24484985</ref>  
Salvinorin A is currently being researched in relation to its properties as an anti-addiction drug, and several analogs with improved pharmacokinetic profiles have been shown to have anti-addictive effects as well.<ref>http://www.ncbi.nlm.nih.gov/pubmed/24484985</ref>
 
===Near-death experience===
A 2019 large-scale study found that [[ketamine]], ''Salvia divinorum'', and [[DMT]] (and other classical psychedelic substances) are linked to [[near-death experience]]s.<ref name="pmid=30711788">{{cite journal |last1=Martial |first1=C |last2=Cassol |first2=H |last3=Charland-Verville |first3=V |last4=Pallavicini |first4=C |last5=Sanz |first5=C |last6=Zamberlan |first6=F |last7=Vivot |first7=RM |last8=Erowid |first8=F |last9=Erowid |first9=E |last10=Laureys |first10=S |last11=Greyson |first11=B |last12=Tagliazucchi |first12=E |title=Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports. |journal=Consciousness and cognition |date=March 2019 |volume=69 |pages=52-69 |doi=10.1016/j.concog.2019.01.011 |pmid=30711788}}</ref>


==Toxicity and harm potential==
==Toxicity and harm potential==